Search results for "Cardiovascular events"
Intensive blood pressure control effective in older frail patients, study finds
Data from SPRINT indicated that frail patients were at higher risk for cardiovascular events than nonfrail patients and benefited similarly from a blood pressure target of less than 120 mm Hg, with no significant increase in adverse events.
https://immattersacp.org/weekly/archives/2023/07/11/2.htm
11 Jul 2023
Cardiovascular effects of vitamin D supplementation still uncertain, trial finds
Older adults who were randomized to vitamin D supplementation had a slightly lower rate of cardiovascular events, particularly myocardial infarction, but the overall difference from placebo was not significant, an Australian trial found.
https://immattersacp.org/weekly/archives/2023/07/04/4.htm
4 Jul 2023
RSV vaccine approved; several actions on opioids
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/06/rsv-vaccine-approved-several-actions-on-opioids.htm
1 Jun 2023
Patients may respond differently to different hypertension drug classes
The authors of a randomized, double-blind, repeated crossover trial in Sweden estimated that personalized antihypertensive therapy could yield an average reduction in systolic blood pressure of 4.4 mm Hg compared to fixed-choice therapy.
https://immattersacp.org/weekly/archives/2023/04/18/1.htm
18 Apr 2023
Calling attention to adult ADHD
Missing an adult diagnosis of attention deficit hyperactivity disorder (ADHD) means patients also miss out on effective, often life-changing treatment.
https://immattersacp.org/archives/2023/04/calling-attention-to-adult-adhd.htm
1 Apr 2023
Separate industry-funded studies find benefit to bempedoic acid as preventive medication, CRP as biomarker
Bempedoic acid reduced cardiovascular (CV) events among patients unwilling or unable to take statins, a trial found, while a review showed that high-sensitivity C-reactive protein (CRP) was a stronger predictor for risk of future CV events and death than cholesterol in patients on statins.
https://immattersacp.org/weekly/archives/2023/03/14/4.htm
14 Mar 2023
Getting to know GLP-1 receptor agonists
Choosing among glucagon-like peptide-1 (GLP-1) receptor agonists depends on many factors, such as the desired outcome and individual risks among patients.
https://immattersacp.org/archives/2023/03/getting-to-know-glp-1-receptor-agonists.htm
1 Mar 2023
Sepsis associated with higher cardiovascular risk after hospitalization
A retrospective cohort analysis of 2.25 million U.S. patients found that those with sepsis were at higher risk for all-cause mortality and rehospitalization for each major type of cardiovascular disease event, particularly heart failure, than those without.
https://immattersacp.org/weekly/archives/2023/02/07/4.htm
7 Feb 2023
MKSAP Quiz: Follow-up for diabetes, hyperlipidemia, hypertension
A 68-year-old man is evaluated during a routine follow-up visit. Medical history is significant for type 2 diabetes mellitus, hyperlipidemia, hypertension, and aortofemoral bypass surgery 2 years ago. Following a physical exam, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2022/11/15/3.htm
15 Nov 2022
Stopping renin-angiotensin system inhibitors in advanced CKD did not appear to affect eGFR
A randomized open-label trial in the United Kingdom found that withdrawal of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in patients with advanced chronic kidney disease (CKD) did not affect estimated glomerular filtration rate (eGFR).
https://immattersacp.org/weekly/archives/2022/11/08/2.htm
8 Nov 2022